Previous
Previous

Discovery of a novel, selective SIK3 inhibitor for the treatment of ulcerative colitis, Crohn’s disease and other autoimmune diseases

Next
Next

Approval of First Clinical Trial Application for Novel SIK inhibitor O3R-5671 in Autoimmune Diseases